Hypoglycemia in a Pediatric Emergency Department: Single-Center Experience on 402 Children

Laura Papini1, Simone Piga2, Carlo Dionisi-Vici3

  • 1From the Pediatric Emergency Department.

Pediatric Emergency Care
|December 4, 2020
PubMed

Insights

Hypoglycemia affects nearly 1 in 1000 children presenting to the emergency department, often due to infections. Metabolic disorders are a rare but serious cause of hypoglycemia in critically ill children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Emergency Medicine

Background:

  • Hypoglycemia is a common metabolic emergency in pediatric patients.
  • Understanding the incidence, causes, and outcomes of hypoglycemia is crucial for timely intervention.

Purpose of the Study:

  • To determine the rate, etiology, and short-term outcomes of hypoglycemia in children admitted to a pediatric emergency department.
  • To identify factors associated with hypoglycemia of different etiologies.

Main Methods:

  • Retrospective analysis of clinical records of children (15 days to 17 years) with hypoglycemia (venous plasma glucose < 45 mg/dL).
  • Data collected over a 6-year period at a tertiary care pediatric hospital.
  • Etiology categorized into infectious causes and hypoglycemia of different etiology (HDE).

Main Results:

  • Hypoglycemia detected in 402 patients (0.99 per 1000 children).
  • Infectious causes (gastroenteritis, protracted fasting) accounted for 86.32% of cases.
  • HDE (13.68%) included ketotic hypoglycemia and rare metabolic defects (1.49%). Severe triage codes were more frequent in HDE.
  • Impaired consciousness and rapid clinical onset (<12 hours) were associated with HDE.

Conclusions:

  • Hypoglycemia is a significant finding in critically ill children.
  • Metabolic disorders, though rare, are important causes of hypoglycemia and should be suspected based on severity, recent onset, and neuroglycopenic symptoms.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
619
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
480
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
438
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
92